Vivos Therapeutics Inc.

NASDAQ: VVOS · Real-Time Price · USD
4.13
-0.48 (-10.41%)
At close: Aug 15, 2025, 12:53 PM

Vivos Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.26M 1.64M 3.52M 24.03M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
216K 307K 374K 356K
Receivables
430K 202K 457K 1.72M
Inventory
n/a n/a n/a n/a
Other Current Assets
783K 616K 1.45M n/a
Total Current Assets
7.47M 2.46M 5.42M 27.32M
Property-Plant & Equipment
4.38M 4.7M 4.78M 2.83M
Goodwill & Intangibles
3.21M 3.26M 3.15M 3.18M
Total Long-Term Assets
7.81M 8.27M 8.3M 6.37M
Total Assets
15.28M 10.73M 13.72M 33.69M
Account Payables
1.1M 2.15M 1.41M 920K
Deferred Revenue
896K 2.14M 2.93M 2.4M
Short-Term Debt
477K 836K 419K 1.26M
Other Current Liabilities
273K 198K 280K 1.46M
Total Current Liabilities
4.98M 7.29M 6.81M 7.51M
Long-Term Debt
n/a n/a n/a 298K
Other Long-Term Liabilities
1.22M 1.22M n/a 343K
Total Long-Term Liabilities
2.35M 3.03M 2.11M 641K
Total Liabilities
7.33M 10.32M 8.92M 8.15M
Total Debt
1.51M 2M 2.41M 1.63M
Common Stock
n/a n/a 2K 2K
Retained Earnings
-104.19M -93.05M -79.47M -55.62M
Comprehensive Income
n/a n/a n/a 0.00
Shareholders Equity
7.95M 411K 4.8M 25.54M
Total Investments
n/a n/a n/a n/a